Levi & Korsinsky Investigates Possible Securities Fraud Violations by Inari Medical, Inc. (NARI)
Levi & Korsinsky Looks into Potential Securities Violations by Inari Medical, Inc. (NARI)
New York, NY / ACCESSWIRE / March 25, 2024 / Levi & Korsinsky is investigating Inari Medical, Inc. (NASDAQ:NARI) for potential breaches of federal securities laws. On February 28, 2024, Inari Medical released its Q4 and full-year 2023 financial results, revealing that the company had received a civil investigative demand from the US Department of Justice regarding payments to healthcare professionals under the federal Anti-Kickback Statute and Civil False Claims Act. Consequently, Inari Medical’s stock dropped over 7% on February 29, 2024.
If you’re looking for more information or wish to participate, visit https://zlk.com/pslra-1/inari-medical-inc-lawsuit-submission-form?prid=72526&wire=1 or reach out to Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by phone at (212) 363-7500.
WHY LEVI & KORSINSKY: With a 20-year history, Levi & Korsinsky LLP is a well-known securities litigation firm that has recovered hundreds of millions of dollars for shareholders and has a strong record of success.
